Catalyst Event
OliX Pharmaceuticals Inc (226950) · Other
From KRX Bio Technology Transfer Index (KBIOTT)
3/24/2026, 12:00:00 AM
Announced positive non-human primate preclinical data for its ALK7-targeting obesity treatment candidate, OLX501A, showing up to 84% target gene suppression, and rebranded its siRNA platform to 'OASIS'. Medium importance estimated due to significant preclinical efficacy in a high-growth obesity market; scheduled.
Korean Translation
ALK7 표적 비만 치료제 후보물질 OLX501A에 대한 영장류 전임상 시험에서 최대 84%의 표적 유전자 발현 억제 효과를 확인하는 긍정적 데이터를 발표하고 siRNA 플랫폼을 'OASIS'로 리브랜딩함. 고성장 비만 치료제 시장에서의 유의미한 전임상 결과로 중간 정도의 영향이 예상됨.
Related Recent Events
Hanmi Pharm Co Ltd (128940) · Other
Annual general shareholder meeting on 2026-03-31 to vote on the appointment of a new CEO and board members amid a management dispute; high impact estimated due to potential governance shift scheduled.
3/31/2026, 12:00:00 AM
LigaChem Biosciences Inc (141080) · Other
The 20th Annual General Shareholders' Meeting on March 31, 2026, to approve financial statements and appoint a new director (Low importance estimated as standard annual meetings without major corporate changes usually have minimal price impact) scheduled
3/31/2026, 12:00:00 AM
Daewoong Pharmaceutical Co Ltd (069620) · Other
The 25th Annual General Meeting of Shareholders is scheduled for March 26, 2026. Low importance is estimated as the agenda items are routine and unlikely to cause significant price volatility scheduled.
3/26/2026, 12:00:00 AM
Chong Kun Dang Pharm Co (185750) · Other
The 13th Annual General Meeting of Shareholders is scheduled.
3/26/2026, 12:00:00 AM
Alteogen Inc (196170) · Other
Alteogen's exclusive license agreement with Biogen for its ALT-B4 technology on March 25, 2026, is expected to have a >10% price impact due to the significant deal size of 867.6 billion KRW, scheduled.
3/25/2026, 12:00:00 AM
AprilBio Co Ltd (397030) · Other
The 13th Annual General Meeting of Shareholders was held on March 25, 2026. Resolutions passed included the approval of the 2025 financial statements, amendments to the articles of incorporation, and the granting of stock options.
3/25/2026, 12:00:00 AM